Peyronie's disease associated with increase in plasminogen activator inhibitor in fibrotic plaque

Urology

Volumn 65, Issue 4, 2005, Pages 645-648

  Davila, Hugo H ^b   Magee, Thomas R ^b   Zuniga, Freddi I ^b   Rajfer, Jacob ^b   Gonzalez Cadavid, Nestor F ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; FIBROBLAST CULTURE; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NUCLEOTIDE SEQUENCE; PEYRONIE DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 17144381703     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.01.010     Document Type: Article

References (17)

1. J.P. Jarow, F.C. Lowe Penile trauma an etiologic factor in Peyronie's disease and erectile dysfunction J Urol 158 1997 1388 1390
2. C.J. Devine Jr, K.D. Somers, S.G. Jordan Proposal trauma as the cause of the Peyronie's lesion J Urol 57 1997 285 290
3. S.S. Gholami, N.F. Gonzalez-Cadavid, C.-S. Lin Peyronie's disease a review J Urol 169 2003 1234 1241
4. U. Schwarzer, F. Sommer, T. Klotz The prevalence of Peyronie's disease results of a large survey BJU Int 88 2001 727 730
5. K.D. Somers, D.M. Dawson Fibrin deposition in Peyronie's disease plaque J Urol 157 1997 311 315
6. H.H. Davila, M.G. Ferrini, J. Rajfer Fibrin as an inducer of fibrosis in the tunica albuginea of the rat a new animal model of Peyronie's disease BJU Int 91 2003 830 838
7. C. Zhang, X. Meng, Z. Zhu Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro Life Sci 75 2004 367 379
8. J. Rey, H. Probst, L. Mazzolai Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings tissue culture versus ex vivo continuous perfusion of human saphenous vein J Surg Res 121 2004 42 49
9. Q. Zhang, Y. Wu, C.H. Chau Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts J Cell Physiol 199 2004 89 97
10. M.G. Ferrini, D. Vernet, T.R. Magee Antifibrotic role of inducible nitric oxide synthase Nitric Oxide 6 2002 283 294
11. A. Qian, R.A. Meals, J. Rajfer Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture Urology 64 2004 399 404
12. E.G. Valente, D. Vernet, M.G. Ferrini l-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures Nitric Oxide 9 2003 229 244
13. D.J. Loskutoff, M. Linders, J. Keijer Structure of the human plasminogen activator inhibitor 1 gene nonrandom distribution of introns Biochemistry 26 1987 3763 3768
14. T method Methods 25 2001 402 408
15. H. Chang, K. Shyu, S. Lin The plasminogen activator inhibitor-1 gene is induced by cell adhesion through the MEK/ERK pathway J Biomed Sci 10 2003 738 745
16. A.I. El-Sakka, H.M. Hassoba, R.J. Pillarisetty Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression J Urol 158 1997 1391 1394
17. H.H. Davila, T.R. Magee, D. Vernet Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibriotic plaque in an animal model of Peyronie's disease Biol Reprod 71 2004 1568 1577